Clinical Trial Update: Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing bone marrow morphology in adults treated with romiplostim for thrombocytopenia associated with idiopathic thrombocytop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura
• Thrombocytopenia

Drugs mentioned

• Romiplostim (romiplostim)

Snippet

Sponsor: Amgen | Conditions: Thrombocytopenia, Idiopathic Thrombocytopenic Purpura | Phase 4 | Status: COMPLETED | Results posted: 2015-01-01